miR-375 Inhibits Cancer Stem Cell Phenotype and Tamoxifen Resistance by Degrading HOXB3 in Human ER-positive Breast Cancer

Oncology Reports - Greece
doi 10.3892/or.2017.5360
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Neuromedin U Alters Bioenergetics and Expands the Cancer Stem Cell Phenotype in HER2-positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

Re-Expression of microRNA-375 Reverses Both Tamoxifen Resistance and Accompanying EMT-like Properties in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Rapamycin Enhances the Sensitivity of ER‑positive Breast Cancer Cells to Tamoxifen by Upregulating P73 Expression

Oncology Reports
MedicineCancer ResearchOncology
2018English

ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2014English

Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

miR-1 Inhibits the Proliferation of Breast Cancer Stem Cells by Targeting EVI-1

OncoTargets and Therapy
OncologyPharmacology
2018English

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells

PLoS ONE
Multidisciplinary
2014English

miR-186 Reverses Cisplatin Resistance and Inhibits The�formation of the Glioblastoma-Initiating Cell�phenotype by Degrading Yin Yang 1 in Glioblastoma

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy